Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
InVivo Therapeutics Holdings Corp. (NVIVQ) had Return on Tangible Equity of -30.24% for the most recently reported fiscal quarter, ending 2023-09-30.
| Income Statement Financials | |
-- |
|
$-2.70M |
|
-- |
|
-- |
|
$2.83M |
|
$-2.83M |
|
$0.13M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.83M |
|
$-2.82M |
|
3.11M |
|
3.11M |
|
$-0.87 |
|
$-0.87 |
|
| Balance Sheet Financials | |
$9.53M |
|
$0.01M |
|
$0.06M |
|
$9.58M |
|
$0.67M |
|
-- |
|
-- |
|
$0.67M |
|
$8.92M |
|
$8.92M |
|
$8.92M |
|
3.10M |
|
| Cash Flow Statement Financials | |
$-7.94M |
|
$0.07M |
|
-- |
|
$16.50M |
|
$8.63M |
|
$-7.87M |
|
$0.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.24% |
|
|
Return on Tangible Equity |
-30.24% |
-28.14% |
|
-30.24% |
|
$2.87 |
|
$-2.53 |
|
$-2.56 |
|